{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ANDREW POLLACK", "person": [{"rank": 1, "role": "reported", "firstname": "Andrew", "organization": "", "lastname": "POLLACK"}]}, "abstract": "DealBook Online; Axovant Sciences raises $315 million in initial public offering, selling 21 million shares at $15 each, largely off of hopes for unproven Alzheimer's disease; is largest initial offering ever in the biotechnology industry, and fuels speculation concerning bubble.", "type_of_material": "News", "word_count": "823", "lead_paragraph": "The company, which bought an unproven Alzheimer\u2019s drug for $5 million, is now valued at nearly $3 billion. The successful debut renews concerns that biotechnology stocks are in bubble territory.", "pub_date": "2015-06-12T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Shares of Axovant, Alzheimer\u2019s Drug Developer, Surge on Trading Debut", "print_headline": "Biotech Debut"}, "snippet": "The company, which bought an unproven Alzheimer\u2019s drug for $5 million, is now valued at nearly $3 billion. The successful debut renews concerns that biotechnology stocks are in bubble territory.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/06/12/business/dealbook/shares-of-axovant-alzheimers-drug-developer-surge-on-trading-debut.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Axovant Sciences Ltd.", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Initial Public Offerings", "name": "subject"}, {"rank": "3", "is_major": "N", "value": "Biotechnology and Bioengineering", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Alzheimer's Disease", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "GlaxoSmithKline PLC", "name": "organizations"}], "blog": [], "_id": "557a021c38f0d82bd01b5058", "source": "The New York Times"}